# Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant

> **NCT00662272** · PHASE1 · COMPLETED · sponsor: **Colby Pharmaceutical Company** · enrollment: 128 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone vaccine with JVRS-100 adjuvant
- **BIOLOGICAL:** Fluzone vaccine
- **BIOLOGICAL:** Fluzone vaccine

## Key facts

- **NCT ID:** NCT00662272
- **Lead sponsor:** Colby Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-10
- **Final completion:** 2009-12
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2010-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662272, "Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00662272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*